Stock listing

OTC:INCPF InnoCare Pharma Ltd. Stock

US listing (OTC) of InnoCare Pharma Ltd. · home listing Shanghai:688428

Follow InnoCare Pharma Ltd. into a list and get an email when it puts out news.

Home listing price · SSE:688428

¥26.03 CNY -0.34 (-1.3%)

Close on Oct 14, 2026 · This listing has no price on 6ix; the price shown is the home listing's, SSE:688428

InnoCare Pharma Ltd. logo
Ticker
OTC:INCPF
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

What changed lately

Calls

Replays

  • Innocare Pharma (Shanghai:688428) Q2 2026 Earnings Call

    Mon, Aug 24, 2026 · 8:30 AM ET

    Watch Transcript

  • Innocare Pharma (Shanghai:688428) Q4 2025 Earnings Call

    Wed, Mar 25, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

Indicative Announcement on Change in Equity Interests of Shareholder Holding More Than 5% of the Shares Reaching 1% Threshold

Oct 1, 2026

Announcement on Vesting Results for the First Vesting Period of the Reserved Grant under the 2024 STAR Market Restricted Share Incentive Plan and Listing of Shares

Sep 15, 2026

InnoCare Announces Approval of Clinical Trial of Novel Bispecific ADC ICP-B381 Targeting PSMA/ STEAP1 in China

Sep 8, 2026

Announcement on the Progress of Acquisition of the Remaining Equity in a Controlled Subsidiary

Sep 8, 2026

Announcement on the Satisfaction of Vesting Conditions for the First Vesting Period of the Reserved Grant under the 2024 STAR Market Restricted Share Incentive Plan

Aug 26, 2026

InnoCare Reports 2026 Interim Results, Sustained Profitability and Key Milestones Achieved

Aug 24, 2026

InnoCare Announces Approval of Head-to-Head Registrational Phase III Trial of Mesutoclax with Azacitidine versus Venetoclax with Azacitidine in Treatment-Naive AML in China

Aug 17, 2026

InnoCare Announces Orelabrutinib in Combination with Mesutoclax Granted Breakthrough Therapy Designation in China

Aug 3, 2026

InnoCare's TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis Study

Jul 27, 2026

Announcement on Results of Shareholding Reduction by Directors and Senior Management Members

Jul 21, 2026

All InnoCare Pharma Ltd. news

Decks

InnoCare Pharma Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
54 in the last 12 months · 104 in all · newest Oct 1, 2026 · oldest 2024
Calls
2 calls with a replay · 2 with a transcript · latest Aug 24, 2026
Decks
16 decks · latest Aug 25, 2026

Where InnoCare Pharma Ltd. is listed

ListingExchangeCountryCurrency
Shanghai:688428 诺诚健华 · Home listingShanghaiChinaCNY
HKEX:9969 諾誠健華HKEXHong KongHKD
LS Exchange:A2PVC2LS ExchangeGermanyEUR
gettex:33CgettexGermanyEUR
OTC:INCPF · This pageOTCUnited StatesUSD
Lang & Schwarz:A2PVC2Lang & SchwarzGermanyEUR
Dusseldorf:33CDusseldorfGermanyEUR
Frankfurt:33CFrankfurtGermanyEUR
Munich:33CMunichGermanyEUR
Stuttgart:33CStuttgartGermanyEUR
Tradegate:33CTradegateGermanyEUR

Log in to ask 6ix AI your own questions about InnoCare Pharma Ltd.